Page 43 - 2020_08-Haematologica-web

Inherited thrombocytopenias
mild and moderate inherited bleeding dis- orders: an EHA consensus report. HemaSphere. 2019;3(5):e286.
133.Noris P, Schlegel N, Kiersy C, et al. Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocy- topenia. Haematologica. 2014;99(8):1387- 1394.
134.Orsini S, Noris P, Bury L, et al. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. Haematologica. 2017;102(7):1192-1203.
135.Gimbrone MA Jr, Aster RH, Cotran RS, Corkery J, Jandl JH, Folkman J. Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature. 1969;222(5188):33-36.
136.Nurden AT. The biology of the platelet with special reference to inflammation, wound healing and immunity. Front Biosci (Landmark Ed). 2018;23:726-751.
137.Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008;111(10): 4958-4964.
138. Poon MC, D’Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: focus on Glanzmann’s thrombasthenia and Bernard-Soulier’s syn- drome. Semin Thromb Haemost. 2018;44(6):604-614.
139.Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC joint VWF and Perinatal/ Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized question- naire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-2065.
140.Gresele P, Orsini S, Noris P, et al. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communi- cation from the Platelet Physiology SSC. J
Thromb Haemost. 2020;18(3):732-739. 141.Fasulo MR, Biquzzi E, Abbattista M, et al. The ISTH bleeding assessment tool and the risk of future bleeding. J Thromb Haemost.
2018;16(1):125-130.
142.Favier R, Roussel X, Audia S, et al.
Correction of severe myelofibrosis, impaired platelet function abnormalities in a patient with gray platelet syndrome suc- cessfully treated by stem cell transplanta- tion. Platelets. 2019 Sep 10:1-5 [Epub ahead of print].
143. Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112-1123.
144.Pecci A, Gresele P, Kiersy C, et al. Eltrombopag for the treatment of the inher- ited thrombocytopenia deriving from MYH9 mutations. Blood. 2010;116(26): 5832-5837.
145.Westbury SK, Downes K, Burney C, et al. Phenotypic description and response to thrombopoietin receptor agonist in DIAPH1-related disorder. Blood Adv. 2018;2(18):2341-2346.
146. Gabelli M, Marzollo A, Notarangelo LD, Basso G, Putti MC. Eltrombopag use in a patient with Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2017;64(12).
147.Pecci A, Ragab I, Bozzi V, et al. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treat- able with romiplostim. EMBO Mol Med. 2018;10(1):63-75.
148.Barbosa M, Joshi RS, Garg P, et al. Identification of rare de novo epigenetic variations in congenital disorders. Nat Commun. 2018;9(1):2064.
149.Fisher MS, Di Paola J. Genomics and tran- scriptomics of megakaryocytes and platelets: implications for health and dis- ease. Res Pract Thromb Haemost. 2018;2
(4):630-639.
150.Almazni I, Stapley R, Morgan NV. Inherited
thrombocytopenia: update on genes and genetic variants which may be associated with bleeding. Front Cardiovasc Med. 2019;6:80.
151. Savoia A. Molecular basis of inherited thrombocytopenias: an update. Curr Opin Hematol. 2016;23(5):486-492.
152.Gieger C, Radakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;489 (7376):201-208.
153.Astle WJ, Elding H, Jiang T, et al. The allel- lic landscape of human blood cell trait vari- ation and links to common complex dis- ease. Cell. 2016;167(5):1415-1429.
154.Stockley J, Morgan NV, Bem D, et al. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 2013;122(25):4090-4093.
155.Guillet B, Bayart S, Pillois X, Nurden P, Caen JP, Nurden AT. A Glanzmann throm- basthenia family associated with a TUBB1- related macrothrombasthenia. J Thromb Haemost. 2019;17(12):2211-2215.
156. Karastaneva A, Nebral K, Schlagenhauf A, et al. Novel phenotypes observed in patients with ETV6-linked leukemia/famil- ial thrombocytopenia syndrome and a bial- lelic ARID5B risk allele as leukaemogenic cofactor. J Med Genet. 2019;jmedgenet- 2019-106339. [Epub ahead of print]
157.Engert A, Balduini C, Brand A, et al. The European Haematology Association roadmap for haematology research: a con- sensus document. Haematologica. 2016; 101 (2):115-208.
158. Greinacher A, Eekels JJM. Simplifying the diagnosis of inherited platelet disorders? The new tools do not make it easier. Blood. 2019;133(23):2478-2483.
haematologica | 2020; 105(8)
2019